{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:47:08Z","timestamp":1790844428957,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Public Health Agency of Canada\/National Microbiology Laboratory","award":["MOA 4500299739"],"award-info":[{"award-number":["MOA 4500299739"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.vaccine.2014.11.016","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T18:58:07Z","timestamp":1416596287000},"page":"346-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant"],"prefix":"10.1016","volume":"33","author":[{"given":"Alessandra","family":"Ricciardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momar","family":"Ndao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2014.11.016_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0001-706X(00)00122-4","article-title":"The global status of schistosomiasis and its control","volume":"77","author":"Chitsulo","year":"2000","journal-title":"Acta Trop"},{"issue":"7","key":"10.1016\/j.vaccine.2014.11.016_bib0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","article-title":"Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk","volume":"6","author":"Steinmann","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"9470","key":"10.1016\/j.vaccine.2014.11.016_bib0015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)66457-4","article-title":"Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis","volume":"365","author":"King","year":"2005","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2014.11.016_bib0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1473-3099(10)70099-2","article-title":"Schistosomiasis elimination: lessons from the past guide the future","volume":"10","author":"Gray","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2014.11.016_bib0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.pt.2006.09.006","article-title":"Transmission control for schistosomiasis \u2013 why it matters now","volume":"22","author":"King","year":"2006","journal-title":"Trends Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.016_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"McManus","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2014.11.016_bib0035","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1371\/journal.pntd.0000244","article-title":"Trick or treat: the role of vaccines in integrated schistosomiasis control","volume":"2","author":"Bergquist","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.016_bib0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/infdis\/174.1.163","article-title":"Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity","volume":"174","author":"Olveda","year":"1996","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2014.11.016_bib0045","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.qco.0000247591.13671.6a","article-title":"Schistosomiasis: challenges for control, treatment and drug resistance","volume":"19","author":"Fenwick","year":"2006","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2014.11.016_bib0050","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1371\/journal.pntd.0000504","article-title":"Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni","volume":"3","author":"Melman","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.016_bib0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S0074-02762011000200006","article-title":"Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails","volume":"106","author":"Couto","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.016_bib0060","first-page":"589","article-title":"Resistance to praziquantel, effect of drug pressure and stability test","volume":"32","author":"Ismail","year":"2002","journal-title":"J Egypt Soc Parasitol"},{"issue":"7253","key":"10.1016\/j.vaccine.2014.11.016_bib0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature08160","article-title":"The genome of the blood fluke Schistosoma mansoni","volume":"460","author":"Berriman","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2014.11.016_bib0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0166-6851(87)90088-0","article-title":"Cloning of diagnostic 31\/32 kilodalton antigens of Schistosoma mansoni","volume":"25","author":"Klinkert","year":"1987","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.016_bib0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0166-6851(89)90025-X","article-title":"Primary structures of Sm31\/32 diagnostic proteins of Schistosoma mansoni and their identification as proteases","volume":"33","author":"Klinkert","year":"1989","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.016_bib0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-6851(03)00194-4","article-title":"Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase","volume":"131","author":"Sajid","year":"2003","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.016_bib0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.molbiopara.2005.06.007","article-title":"Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth","volume":"143","author":"Correnti","year":"2005","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.016_bib0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/IAI.61.1.146-154.1993","article-title":"Candidate vaccine antigens identified by antibodies from mice vaccinated with 15- or 50-kilorad-irradiated cercariae of Schistosoma mansoni","volume":"61","author":"Richter","year":"1993","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2014.11.016_bib0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4269\/ajtmh.1990.42.335","article-title":"Antibody response to Schistosoma mansoni adult worm cysteine proteinases in infected individuals","volume":"42","author":"Chappell","year":"1990","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2014.11.016_bib0100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1365-3156.1998.00298.x","article-title":"Diagnostic significance of Schistosoma mansoni proteins Sm31 and Sm32 in human schistosomiasis in an endemic area in Egypt","volume":"3","author":"El-Sayed","year":"1998","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.016_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S0022149X00011305","article-title":"Diagnostic Mr31\/32,000 Schistosoma mansoni proteins (Sm31\/32): reaction with sera from Sudanese patients infected with S. mansoni or S. haematobium","volume":"62","author":"Idris","year":"1988","journal-title":"J Helminthol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.016_bib0110","first-page":"65","article-title":"Boost effect of recombinant IL-4 on protection of Schistosoma japonicum cathepsin B DNA vaccine in mice against the parasite","volume":"23","author":"Chen","year":"2005","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng"},{"issue":"7","key":"10.1016\/j.vaccine.2014.11.016_bib0115","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.vaccine.2005.08.076","article-title":"DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime\/protein boost strategy","volume":"24","author":"Kennedy","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.016_bib0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4161\/hv.22950","article-title":"TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36\/AHG malaria vaccine in nonhuman primate models","volume":"9","author":"Tougan","year":"2013","journal-title":"Hum Vaccines Immunother"},{"issue":"52","key":"10.1016\/j.vaccine.2014.11.016_bib0125","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1016\/j.vaccine.2009.10.087","article-title":"A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1\/Alhydrogel+CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults","volume":"27","author":"Sagara","year":"2009","journal-title":"Vaccine"},{"issue":"10\u201311","key":"10.1016\/j.vaccine.2014.11.016_bib0130","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.micinf.2008.06.002","article-title":"Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice","volume":"10","author":"Iborra","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2014.11.016_bib0135","doi-asserted-by":"crossref","first-page":"181690","DOI":"10.1155\/2010\/181690","article-title":"BALB\/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge","volume":"2010","author":"Ramirez","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"9","key":"10.1016\/j.vaccine.2014.11.016_bib0140","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.vaccine.2012.12.071","article-title":"Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis","volume":"31","author":"Ramirez","year":"2013","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2014.11.016_bib0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-3024.2005.00764.x","article-title":"Immunity induced by the radiation attenuated schistosome vaccine","volume":"27","author":"Hewitson","year":"2005","journal-title":"Parasite Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2014.11.016_bib0150","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.4049\/jimmunol.163.8.4489","article-title":"TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine","volume":"163","author":"Street","year":"1995","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2014.11.016_bib0155","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0035-9203(94)90436-7","article-title":"Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni","volume":"88","author":"Viana","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.11.016_bib0160","volume":"vol. 103","author":"Tucker","year":"2013"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2014.11.016_bib0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2014.11.016_bib0170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0264-410X(01)00268-7","article-title":"Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge","volume":"20","author":"Plante","year":"2001","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2014.11.016_bib0175","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1128\/IAI.72.9.5526-5529.2004","article-title":"Parameters of the attenuated schistosome vaccine evaluated in the olive baboon","volume":"72","author":"Kariuki","year":"2004","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.016_bib0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4269\/ajtmh.1979.28.274","article-title":"Schistosoma mansoni infections in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum II Pathology","volume":"28","author":"Byram","year":"1979","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2014.11.016_bib0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4269\/ajtmh.1979.28.260","article-title":"Schistosoma mansoni infections in T-cell deprived mice, and the ameliorating effect of administering homologous chronic infection serum I pathogenesis","volume":"28","author":"Doenhoff","year":"1979","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.vaccine.2014.11.016_bib0190","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.136.7.2644","article-title":"Passive transfer with serum and IgG antibodies of irradiated cercariae-induced resistance against Schistosoma mansoni in mice","volume":"136","author":"Mangold","year":"1986","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2014.11.016_bib0195","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.vaccine.2011.01.040","article-title":"Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models","volume":"29","author":"Torben","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2014.11.016_bib0200","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1371\/journal.pntd.0000290","article-title":"Elimination of Schistosoma mansoni adult worms by rhesus macaques: basis for a therapeutic vaccine?","volume":"2","author":"Wilson","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2014.11.016_bib0205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pt.2009.05.011","article-title":"Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour","volume":"25","author":"Wilson","year":"2009","journal-title":"Trends Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.11.016_bib0210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.173.1.159","article-title":"Downregulation of Thl cytokine production accompanies induction of Th2 responses by a parasitic helrninth, Schistosoma mansoni","volume":"173","author":"Pearce","year":"1991","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2014.11.016_bib0215","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20082460","article-title":"Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses","volume":"206","author":"Everts","year":"2009","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2014.11.016_bib0220","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.146.4.1322","article-title":"Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni","volume":"146","author":"Grzych","year":"1991","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2014.11.016_bib0225","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.4049\/jimmunol.178.10.6023","article-title":"Cutting edge: IPSE\/alpha-1, a glycoprotein from Schistosoma mansoni eggs, induces IgE-dependent, antigen-independent IL-4 production by murine basophils in vivo","volume":"178","author":"Schramm","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2014.11.016_bib0230","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.4049\/jimmunol.181.10.7214","article-title":"IL-10 and TGF-\u03b2 redundantly protect against severe liver injury and mortality during acute schistosomiasis","volume":"181","author":"Herbert","year":"2008","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2014.11.016_bib0235","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.4049\/jimmunol.164.12.6406","article-title":"IL-10 and the dangers of immune polarization: excessive Type 1 and Type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis","volume":"164","author":"Hoffman","year":"2000","journal-title":"J Immunol"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2014.11.016_bib0240","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.actatropica.2008.05.004","article-title":"Aging and immune response in chronic human schistosomiasis","volume":"108","author":"Comin","year":"2008","journal-title":"Acta Trop"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14015412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14015412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T12:30:23Z","timestamp":1689683423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14015412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0264410X14015412"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}